EyePoint (EYPT) Current Deferred Revenue (2011 - 2025)
EyePoint (EYPT) reported Current Deferred Revenue of $5.1 million for Q1 2025, down 86.67% on a YoY basis from $38.4 million in Q1 2024, and down 71.24% sequentially from $17.8 million in Q4 2024.
EyePoint (EYPT) Current Deferred Revenue (2011 - 2025) Analysis & Trends
EyePoint (EYPT) has 15 years of Current Deferred Revenue data on file, last reported at $5.1 million in Q1 2025.
- For the quarter ending Q1 2025, Current Deferred Revenue fell 86.67% year-over-year to $5.1 million; the trailing twelve-month figure through Mar 2025 stood at $5.1 million (down 86.67% YoY), and the FY2024 full-year result was $17.8 million, down 53.92% from the prior year.
- Current Deferred Revenue eased to $5.1 million in Q1 2025, from $17.8 million in the prior quarter.
- In the past five years, Current Deferred Revenue ranged from a high of $42.1 million in Q2 2023 to a low of $973000.0 in Q1 2021.
- A 5-year average of $14.8 million and a median of $1.2 million in 2023 frame the typical range for Current Deferred Revenue.
- Across the five-year window, Current Deferred Revenue soared 3601.32% in 2023 and plunged 86.67% in 2025, its largest moves.
- Tracing EYPT's Current Deferred Revenue over 5 years: stood at $1.1 million in 2021, then gained by 12.72% to $1.2 million in 2022, then jumped by 3102.66% to $38.6 million in 2023, then tumbled by 53.92% to $17.8 million in 2024, then sank by 71.24% to $5.1 million in 2025.
- Business Quant data shows EYPT's Current Deferred Revenue at $5.1 million in Q1 2025, $17.8 million in Q4 2024, and $26.0 million in Q3 2024.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | EyePoint | 358.61 Mn | 136.07 Mn | 168,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2025 | 5.12 Mn |
| Dec 31, 2024 | 17.78 Mn |
| Sep 30, 2024 | 26.00 Mn |
| Jun 30, 2024 | 33.34 Mn |
| Mar 31, 2024 | 38.38 Mn |
| Dec 31, 2023 | 38.59 Mn |
| Sep 30, 2023 | 39.84 Mn |
| Jun 30, 2023 | 42.08 Mn |
| Mar 31, 2023 | 1.24 Mn |
| Dec 31, 2022 | 1.21 Mn |
| Sep 30, 2022 | 1.17 Mn |
| Jun 30, 2022 | 1.14 Mn |
| Mar 31, 2022 | 1.10 Mn |
| Dec 31, 2021 | 1.07 Mn |
| Sep 30, 2021 | 1.04 Mn |
| Jun 30, 2021 | 1.01 Mn |
| Mar 31, 2021 | 973,000.00 |
| Dec 31, 2020 | 945,000.00 |
| Sep 30, 2020 | 300,000.00 |
| Mar 31, 2020 | 30,000.00 |